v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Current Assets:    
Cash and cash equivalents $ 1,894,351 $ 3,619,949
Stock subsciption receivable   500,000
Other current assets 1,790,389 501,187
Total Current Assets 3,684,740 4,621,136
Property and equipment, net 407,794 300,639
Operating right-of-use assets 270,949 384,530
Other noncurrent assets 33,754 33,769
Goodwill 10,738,082 10,738,082
In-process research and development 11,275,000 11,275,000
Prepaid research and development expenses 2,915,050  
Revolving credit facility debt issuance costs, net 6,918,225  
Total Assets 36,243,594 27,353,156
Current Liabilities:    
Accounts payable and accrued expenses 7,196,635 5,720,241
Revolving credit facility - interest and annual fee 339,583  
Lease liabilities, current 221,679 199,041
Total Current Liabilities 7,757,897 5,919,282
Long-term Liabilities:    
Revolving credit facility borrowings, related party 9,200,000 0
Lease liability, long term 134,254 303,627
Deferred tax liability 197,919 197,919
Total Liabilities 17,290,070 6,420,828
Stockholders's Equity:    
Common stock, $0.001 par value, 200,000,000 shares authorized; 65,758,417 and 59,336,104 shares issued and outstanding as of September 30, 2026 and December 31, 2025. 65,758 59,336
Additional paid-in capital 182,969,886 161,779,364
Accumulated deficit (164,360,650) (141,184,902)
Total Stockholders' Equity 18,953,524 20,932,328
Total Liabilities and Stockholders' Equity 36,243,594 27,353,156
Preferred Stock Series A [Member]    
Stockholders's Equity:    
Preferred Stock $ 278,530 $ 278,530